Bloodworks Northwest

HLA or family-matched apheresis platelet components.

Adult dose apheresis platelets transfusion component.

Platelets suspended in additive solution.

Polymerase Chain Reaction (PCR) based red cell genotyping service for a single blood group antigen system, utilized to predict red blood cell phenotypes or resolve ambiguous serological typings.

Genomic testing services provided by Bloodworks' Genomics Testing Laboratory to analyze genetic markers related to blood groups.

Subset of genotyping for common variants using polymerase chain reaction (PCR) based methods.

Genomic testing specifically for the MNS blood group system.

Red cell phenotyping service limited to C, c, E, e, K antigens.

Screening service for red cell alloantibodies in blood donors.

Sequencing test for red cell blood groups requiring prior authorization.

An immunohematology reference laboratory test that detects the presence of unexpected allo- or auto-antibodies against red blood cell antigens.

Granulocyte transfusion components for patients with low neutrophils.

Granulocyte transfusion components requiring prior approval.

HLA antibody screening service aimed at transfusion-related acute lung injury (TRALI) mitigation.

Antibody testing service to detect Toxoplasma gondii infection in donors.

Serological testing service for Epstein Barr Virus viral capsid antibodies.

Serological testing service for Epstein Barr Virus nuclear antigen antibodies.

Cryoprecipitate prepared from plasma containing fibrinogen, von Willebrand factor, factor VIII, factor XIII, and fibronectin, available in pre-pooled concentrates of five units or single units.

Cryoprecipitate transfusion products available as single or 5-unit pools.

HLA typing test associated with ankylosing spondylitis and other arthropathies.

HLA typing test associated with ankylosing spondylitis and other arthropathies.

HLA-B*5701 typing test associated with Abacavir hypersensitivity.

HLA-B*5801 typing test associated with Allopurinol hypersensitivity.

HLA-B*1502 typing test associated with Carbamazepine hypersensitivity.

Molecular testing service for the detection of Babesia parasites in blood donors.

Molecular testing service for West Nile Virus in volunteer blood donations.

Laboratory test for qualitative detection of human immunodeficiency virus antibodies and antigens used in blood donor, patient, and organ donor testing.

Infectious disease testing service to detect HIV-1 and HIV-2 antibodies.

Laboratory test for qualitative detection of human immunodeficiency virus antibodies and antigens used in blood donor, patient, and organ donor testing.

Antibody to human immunodeficiency virus types 1 and 2 test.

Antibody to human T-lymphotropic virus types I and II test.

Antibody to cytomegalovirus test.

Antibody to hepatitis C virus test.

Antibody to hepatitis B core antigen test.

Infectious disease testing service for Syphilis using the Rapid Plasma Reagin method.

Infectious disease testing service for Syphilis using anti-Treponema pallidum assays.

Testing to determine paternal or individual RhD zygosity.

Polymerase Chain Reaction (PCR) based molecular test for RhD zygosity and CDE Systems to help predict fetal compatibility to the mother.

Immunogenetics testing for HLA Class I A, B, and C antigens.

Immunogenetics testing for HLA Class I A, B, and C antigens.

Immunogenetics testing for HLA Class II DR and DQ antigens.

Infectious disease testing service to detect Hepatitis B surface antigen.

Infectious disease testing service to detect Hepatitis B surface antigen.

Infectious disease testing service to detect Hepatitis B core antibodies.

Laboratory workup for Post Transfusion Purpura (PTP) utilizing flow cytometry, PCR, and ELISA to detect strong positive antibody results against platelets and the absence of common platelet antigens.

Platelet genotyping laboratory workup for Post Transfusion Purpura.

Comprehensive evaluation workup for neonatal alloimmune thrombocytopenia involving maternal and paternal samples.

Evaluation test for Neonatal Alloimmune Thrombocytopenia.

Laboratory assay to detect drug-dependent platelet antibodies.

Laboratory testing service for drug-related immune thrombocytopenia.

Diagnostic test for platelet autoantibodies and ITP workup.

Diagnostic test for platelet autoantibodies and ITP workup.

Laboratory testing service for platelet autoantibodies.

ADAMTS 13 activity functional assay requiring citrate plasma.

ADAMTS 13 inhibitor test performed if activity level is less than 30%.

ADAMTS 13 antibody test performed if activity level is less than 30%.

Laboratory assay for ADAMTS-13 protease activity and inhibitor.

HLA-DQB1/DQA1 typing test associated with Celiac disease.

HLA-DQB1*0602 typing test associated with Narcolepsy.

HLA-DQB1/DQA1 typing test associated with Celiac disease.

Comprehensive Heparin Antibody Test targeting IgG, IgA, and IgM via Platelet Factor 4 ELISA.

Laboratory test for heparin-induced thrombocytopenia antibodies.

Leukoreduced red blood cell units supplied for hospital transfusions.

Specialized blood products intended for diagnostic and laboratory use.

Removal of leukocytes by filtration of platelets and red blood cell concentrates.

Removal of white cells either through filtration or special collection techniques to prevent febrile transfusion reactions and reduce HLA alloimmunization.

Autologous red blood cell units collected for patient-specific transfusions.

Frozen red blood cells component.

Service providing crossmatch compatible red blood cell units.

Specialized cryoprecipitate product for patients who cannot accept plasma.

RBC AS-3 Divided Unit supplied as ~40mL aliquots for small volume pediatric transfusions, designed to reduce donor exposure.

Immunogenetics and HLA testing services providing reference resources and trial support.

Reconstituted red blood cell units.

Pooled cryoprecipitate-reduced plasma transfusion product.

HLA testing profile for post-transplant testing services.

Quality control testing service to evaluate residual white blood cell counts in leukoreduced products.

HLA testing profile for support of candidates for transplant.

Specialized screening service for anti-A and anti-B titers/antibodies in apheresis platelets.

HLA testing profile for initial evaluation of recipient and potential donors for living renal donor transplant.

Washed red blood cell units.

Diagnostic or immunotherapy testing services for individual HLA alleles.

HLA testing profile for HLA antibody identification to support platelet transfusion.

HLA testing profile for final crossmatch for deceased donor transplant.

Specialized immunohematology laboratory testing for identifying ABO subgroups.

Discriminatory testing by AmpliScreen.

Reconstituted Whole Blood composed of AS-3 leukocyte reduced, HbS negative, and irradiated red cells and AB plasma.

Deglycerolized red blood cells derived from frozen units.

HLA testing profile for periodic HLA antibody screening of candidates for deceased donor transplant.

Fluid portion of blood that contains coagulation factors required for proper clot formation.

Cryoprecipitated antihemophilic factor transfusion product.

Service providing antigen negative red blood cell units.

Specialized genomics testing and reference services focusing on red cell and bleeding disorders.

Nucleic acid test for HCV, HIV, and HBV (Donor samples only).

Multiplex nucleic acid testing service for Hepatitis C virus, HIV, and Hepatitis B virus.

Reference laboratory services focusing on detecting platelet-specific antigens and antibodies to aid in the identification of compatible platelet donors and manage immunologically mediated platelet disorders.

Extended human platelet antigen genotyping service.

Plasma frozen within 24 hours of collection.

Immunohematology profile service for long-term marrow transplant recipient follow-up.

Determination of the presence or absence of specific red cell antigens including K, Fya, Fyb, Jka, Jkb, S, and s for transfusion safety and antibody identification.

An immunohematology reference laboratory service that determines red blood cell antibody specificity by reacting patient serum with an extended panel of reagent red blood cells.

Laboratory assay to detect total antibodies to Cytomegalovirus in donors.

Adult plasma transfusion product approximately 250mL.

Frozen plasma transfusion products including FFP and FP24.

Quality control testing service to measure platelet product counts.

Immunohematology profile service for the resolution of ABO discrepancy.

Irradiated blood components to prevent transfusion-associated graft-versus-host disease.

Antigen screening for compatible RBC unit(s) using patient serum/plasma performed via standard test tube, gel column or Capture solid phase technology.

Inventory of fresh and frozen antigen-negative red cell units maintained to support patients with single or multiple antibodies or high-prevalence antibodies.

CMV sero-negative blood components intended for severely immunosuppressed patients and premature infants to prevent primary CMV infection.

Molecular testing to identify RhD variant weak D types 1, 2, and 3.

Antigen-negative red cell units for patients with specific alloantibodies.

Standard test for Syphilis.

Testing profile that includes HBsAg, anti-HBc, anti-HCV, anti-HTLV-I/II, anti-HIV-1/HIV-2, and STS for recipient or patient evaluations.

Specific typing test for HLA-A2 or A*0201.

Biological products supplied for research purposes.

Testing profile designed for blood donor screening including HBsAg, anti-HBc, anti-HCV, anti-HTLV-I/II, anti-HIV-1/HIV-2, STS, anti-T. cruzi, and HCV/HIV/HBV/WNV NAT.

Specialized laboratory testing services focused on compatibility testing.

Molecular test for determining ABO blood group genetics.

Removal of donor plasma to accommodate patients sensitive to volume or experiencing allergic reactions.

Test used to detect HLA alloantibodies in multiple transfused patients who may have become alloimmunized to non-self HLA and may require HLA-selected platelet transfusions.

HTLV-I/II confirmatory test.

Frozen plasma prepared in 50 ml aliquots specifically for pediatric use.

West Nile Virus nucleic acid test (Donor samples only).

Immunohematology profile service for hemolysis evaluation.

HIV-1/HIV-2 confirmatory test.

Antibody testing service to screen for Trypanosoma cruzi infection.

Serological antibody testing service for Strongyloides infection screening.

Infectious disease testing service to detect Hepatitis C antibodies.

Specialized testing services focusing on donor testing and virology.

In vitro chemiluminescent immunoassay for the qualitative detection of antibodies to hepatitis C virus in serum or plasma.

Antibody to Trypanosoma cruzi test (Donor samples only).

Reentry testing profile including anti-HBc, HBsAg, and HBV NAT.

Laboratory test used to detect red blood cell antibodies in serum or plasma.

Laboratory testing service for the determination of Rh and K antigen phenotype of a sickle cell disease patient who is likely to receive multiple red cell transfusions.

Hepatitis B surface antigen individual test.

Epstein-Barr Virus Viral Capsid Antigen IgG test.

Gamma irradiation process for blood components to inactivate lymphocytes and prevent transfusion-induced graft-versus-host disease (GVHD).

Can be used as an alternative source for AB plasma in emergencies.

Reentry testing profile including anti-HIV-1/HIV-2 and HIV NAT.

Laboratory test and assay for the qualitative detection of hepatitis B surface antigen in human serum and plasma used for blood, organ, and tissue donor testing.

An evaluation service for patients experiencing unexplained symptoms or fever during or following a blood transfusion to assess for acute or delayed hemolytic transfusion reactions.

Epstein-Barr Virus Nuclear Antigen IgG test.

Red blood cells and platelets sourced from a Cytomegalovirus (CMV) seronegative donor.

Hepatitis B surface antigen confirmatory test.

Reentry testing profile including anti-HCV and HCV NAT.

Toxoplasma IgG antibody test.

Compatibility testing service including ABO/Rh and antibody screen on the recipient performed to confirm ABO compatibility.

Heparin/PF4 IgG ELISA assay using citrate plasma.

Specialized testing and consultative services in hemostasis and thrombosis.

Polymerase Chain Reaction (PCR) based test performed for investigation of RhD typing discrepancies and Red Cell (HEA) Genomics.

Molecular test to detect West Nile Virus RNA.

Detects the presence of red blood cell-bound IgG and/or complement (C3) by agglutination using both polyclonal and monospecific antiglobulin (Coombs) reagents.

HLA-B51 typing test associated with Behcet’s Disease.

HLA-A29 typing associated with Birdshot Retinopathy.

Targeted platelet typing for a single platelet antigen.

HLA-B27 typing test associated with Ankylosing Spondylitis and related arthropathies.

Storage serum test for patients awaiting kidney and or pancreas deceased donor transplantation to ensure a current sample is available for potential final crossmatch testing.

Compatibility testing including ABO/Rh and antibody screen on the recipient to confirm ABO compatibility and perform an electronic crossmatch if the screen is negative and criteria are met.

Patient sample is held for 72 hours and then discarded without performing testing, with the option to convert to a Type and Screen or a crossmatch via telephone or fax.